文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

NEXIS试验:床旁骑行联合静脉氨基酸对急性呼吸衰竭患者的随机试验

Nutrition and Exercise in Critical Illness (NEXIS) trial: randomized trial of combined in-bed cycling and intravenous amino acid plus usual care.
PubMed 文献 · Am J Respir Crit Care Med · 2026-07-13
一句话结论急性呼吸衰竭患者早期床旁骑行联合静脉氨基酸补充安全但未改善出院时6分钟步行距离或次要结局。

NEXIS是一项多中心2期随机试验,纳入115例急性呼吸衰竭患者(中位年龄约55岁,55%男性,APACHE II约24,>90%机械通气),1:1随机分配至方案化床旁骑行(45分钟/日)联合静脉氨基酸(总蛋白摄入2.0-2.5 g/kg/d)加常规治疗组或单独常规治疗组。主要终点为出院时盲法评估的6分钟步行距离(6MWD)。中位差10米,95%CI -75至84)。次要结局(ICU和出院时功能指标及6个月电话随访)两组亦相似。因招募缓慢提前终止,未见安全性问题。

要点

  • 干预方案为床旁骑行45分钟/日联合静脉氨基酸使总蛋白摄入达2.0-2.5 g/kg/d;实际干预组骑行40±7分钟/日,总蛋白摄入1.9±0.6 g/kg/d,对照组0.9±0.6 g/kg/d。
  • 干预组与对照组在ICU和出院时功能指标及6个月电话随访的次要结局均相似。
  • 该联合干预在急性呼吸衰竭患者中 appear safe,未见安全性问题,但因招募缓慢提前终止。
  • 研究为2期试验,计划样本量128例可评估患者(每组64例),实际随机115例(干预组60例,对照组55例)。

适用人群与场景

  • ICU内急性呼吸衰竭(ARF)患者,中位年龄约55岁,55%男性,APACHE II约24,>90%机械通气。
  • 多中心2期随机试验,纳入标准为ICU内急性呼吸衰竭;排除标准原文未提及。

诊断标准与关键阈值

  • 原文未提及

处置流程与药物剂量

  • 干预组:方案化床旁骑行45分钟/日联合静脉氨基酸,使总蛋白摄入达2.0-2.5 g/kg/d,加常规治疗;实际骑行40±7分钟/日,总蛋白摄入1.9±0.6 g/kg/d。
  • 对照组:仅常规治疗,实际总蛋白摄入0.9±0.6 g/kg/d。
  • 主要终点为出院时盲法评估的6分钟步行距离(6MWD)。

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 多中心2期随机试验,115例患者随机(干预组60例,对照组55例),计划样本量128例可评估患者(每组64例),因招募缓慢提前终止,未见安全性问题。
  • 次要结局:ICU和出院时功能指标及6个月电话随访两组相似。
  • 干预实际执行:骑行40±7分钟/日(对照组0分钟/日),总蛋白摄入1.9±0.6 g/kg/d(对照组0.9±0.6 g/kg/d)。

证据类型、等级与局限

  • 证据类型:多中心2期随机对照试验(RCT),意向性分析(intention to treat),盲法评估主要终点。
  • 局限:因招募缓慢提前终止,实际样本量小于计划(115例 vs 计划128例可评估);原文未给出证据等级或推荐强度。

对床旁实践的改变

  • 对于ICU内急性呼吸衰竭患者,早期床旁骑行联合静脉氨基酸补充(总蛋白2.0-2.5 g/kg/d) appear safe,但不应期望其改善出院时6MWD或住院期间及6个月随访的次要功能结局。
  • 该干预方案在急性呼吸衰竭患者中未显示功能获益,临床决策时应考虑其他策略;原文未提及其他适用或不适用人群。

指南或共识出处

  • NEXIS trial: Nutrition and Exercise in Critical Illness Trial, ClinicalTrials.gov (NCT03021902); 发表于Am J Respir Crit Care Med。

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

RATIONALE: Patients with acute respiratory failure (ARF) in intensive care units (ICUs) often experience immobility and limited nutritional intake, with long-lasting impairments.

OBJECTIVE: Evaluate whether combined in-bed cycling exercise and intravenous amino acid, initiated early in the ICU, improves physical functioning.

METHODS: This multicenter phase 2 trial randomly allocated patients 1:1 to protocolized in-bed cycling (45 min/d) plus intravenous amino acid (total protein intake: 2.0-2.5 g/kg/d) plus usual care vs usual care alone. Blinded assessment of 6-minute walk distance (6MWD) at hospital discharge was the primary outcome. Secondary outcomes included functional measures at ICU and hospital discharge, along with phone surveys at the 6-month follow-up. Patients were analyzed according to intention to treat. The planned sample size was 128 evaluable patients (64 per arm).

MEASUREMENTS AND MAIN RESULTS: In total, 115 patients (median age ∼55 years, 55% male, Acute Physiology and Chronic Health Evaluation II ∼24, >90% mechanically ventilated) were randomized (60 intervention; 55 control). Enrollment was stopped early due to slow recruitment, with no evidence of safety concerns. The mean duration of cycling was 40 ± 7 min/d (control: 0 min/d), with total protein intake of 1.9 ± 0.6 g/kg/d (control: 0.9 ± 0.6). The median (interquartile range) 6MWD was similar between intervention and control: 108 (15-242) and 95 (0-196) m (P = .51) (median difference, 10; 95% CI, -75 to 84). Secondary outcomes were also similar between groups.

CONCLUSION: Among patients with ARF, a combined intervention of early in-bed cycling and amino acid supplementation appeared safe but did not improve 6MWD or secondary outcomes during hospitalization or 6-month follow-up. Clinicaltrials.gov (NCT03021902).

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Needham DM, Files DC, Hough CL, et al. Nutrition and Exercise in Critical Illness (NEXIS) trial: randomized trial of combined in-bed cycling and intravenous amino acid plus usual care. Am J Respir Crit Care Med. 2026. PMID: 42438140. doi:10.1093/ajrccm/aamag287

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。